Company · Healthtech & Bio

Devon Labs

devonlabs.com ↗ ·Madrid ·Seed

Devon Labs is a Madrid-based pharmaceutical company that sells its own range of medicines and medical devices in three therapeutic areas: oncology, pain, and disorders of the central nervous system (CNS), including neurodegenerative diseases. It serves physicians, patients and caregivers, and pairs its products with digital telemedicine and patient- and caregiver-support tools. The company was founded in Madrid in 2019 by Gabriel Pérez Cuevas, a pharmaceutical executive who previously served as Senior Vice President for Southern Europe at Kyowa Kirin. In July 2022 it raised €4.5 million from Inveready through a mix of venture capital and venture debt from the Inveready Biotech III and Inveready Venture Finance III funds, to expand its commercial team across Spain and acquire exclusive rights to new products.

Founded

2019

Founders

News

Rounds

Investors

SectorsPharmaceuticals, Medical Devices, Digital Health, Oncology, Pain Management, CNS Start-up MapHealthtech & Bio

Profile updated 24 Sep 2026

Founders

Gabriel Pérez Cuevas

CEO & Founder

Global models

No comparables on record yet.

Investors 1

Inveready

www.inveready.com

Investor Spain

Funding rounds 1

Series A · €4.5M

Inveready invested €4.5M in Madrid pharmaceutical company Devon Labs (legal name Devon Farmacéutica), combining equity from Inveready Biotec…

2022-07-07

News & media

No coverage on record yet.